DK1560581T3 - Oromucosal formulering og fremgangsmåde for fremstilling deraf - Google Patents

Oromucosal formulering og fremgangsmåde for fremstilling deraf

Info

Publication number
DK1560581T3
DK1560581T3 DK03810489T DK03810489T DK1560581T3 DK 1560581 T3 DK1560581 T3 DK 1560581T3 DK 03810489 T DK03810489 T DK 03810489T DK 03810489 T DK03810489 T DK 03810489T DK 1560581 T3 DK1560581 T3 DK 1560581T3
Authority
DK
Denmark
Prior art keywords
preparation
oromucosal formulation
oromucosal
formulation
Prior art date
Application number
DK03810489T
Other languages
English (en)
Inventor
Paeivi Juujaervi
Jukka Ilkka
Juha-Matti Savola
Original Assignee
Juvantia Pharma Ltd Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Juvantia Pharma Ltd Oy filed Critical Juvantia Pharma Ltd Oy
Application granted granted Critical
Publication of DK1560581T3 publication Critical patent/DK1560581T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK03810489T 2002-11-08 2003-11-10 Oromucosal formulering og fremgangsmåde for fremstilling deraf DK1560581T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20022007A FI20022007A0 (fi) 2002-11-08 2002-11-08 Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
PCT/FI2003/000850 WO2004041271A1 (en) 2002-11-08 2003-11-10 Oromucosal formulation and process for preparing the same

Publications (1)

Publication Number Publication Date
DK1560581T3 true DK1560581T3 (da) 2007-05-14

Family

ID=8564916

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03810489T DK1560581T3 (da) 2002-11-08 2003-11-10 Oromucosal formulering og fremgangsmåde for fremstilling deraf

Country Status (20)

Country Link
US (1) US8653122B2 (da)
EP (1) EP1560581B1 (da)
JP (1) JP4739758B2 (da)
KR (1) KR20050072820A (da)
CN (1) CN1711083B (da)
AU (1) AU2003276317B2 (da)
BR (1) BR0316071A (da)
CA (1) CA2505139C (da)
DE (1) DE60311134T2 (da)
DK (1) DK1560581T3 (da)
ES (1) ES2280846T3 (da)
FI (1) FI20022007A0 (da)
IL (1) IL167889A (da)
MX (1) MXPA05004842A (da)
NO (1) NO333977B1 (da)
NZ (1) NZ539690A (da)
PL (1) PL211756B1 (da)
PT (1) PT1560581E (da)
RU (1) RU2336875C2 (da)
WO (1) WO2004041271A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1611548A1 (en) 2003-03-27 2006-01-04 Koninklijke Philips Electronics N.V. Medical imaging system and a method for segmenting an object of interest.
EP1848270B1 (en) 2005-02-17 2014-05-21 Abbott Laboratories Transmucosal administration of drug compositions for treating and preventing disorders in animals

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
NO852655L (no) 1985-06-05 1986-12-08 Bio Data Corp Fremgangsmaate ved fremstilling av koaguleringsreagens for blodplasma i mikrokonsentrert tablettform.
US4855326A (en) 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
US5079018A (en) 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
JP3412694B2 (ja) 1989-10-02 2003-06-03 シーマ・ラブス、インコーポレイテッド 発泡性投与剤
GB2244431A (en) * 1990-05-31 1991-12-04 Farmos Oy Treatment of age related memory impairment and other cognitive disorders
US5541211A (en) 1991-06-18 1996-07-30 Orion-Yhtyma Oy Administration of atipamezole to elicit a yohimbine-like alpha-adrenoreceptor antagonistic noradrenergic transmission
GB9127050D0 (en) * 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use
RU2109509C1 (ru) 1991-12-24 1998-04-27 Яманути Фармасьютикал Ко., Лтд. Композиция для буккального введения лекарственного средства и способ ее получения
US5298261A (en) 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
GB9425211D0 (en) * 1994-12-14 1995-02-15 Ucb Sa Substituted 1H-imidazoles
PT914818E (pt) 1996-06-14 2005-08-31 Kyowa Hakko Kogyo Kk Comprimido de desintegracao rapida por via intraoral
DE19646392A1 (de) 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
FR2773489B1 (fr) * 1998-01-15 2001-03-23 Immunotech Sa Nouvelle composition destinee a la voie oromuqueuse notamment pernasale
FR2781152B1 (fr) 1998-07-20 2001-07-06 Permatec Tech Ag Utilisation d'un polymere de type acrylique en tant qu'agent de desagregation
JP2000095674A (ja) 1998-09-22 2000-04-04 Sato Pharmaceutical Co Ltd 口腔内崩壊時間短縮化錠剤の製造方法及び装置
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
TW592709B (en) * 1999-04-29 2004-06-21 Janssen Pharmaceutica Nv Prucalopride oral solution
GB9910505D0 (en) 1999-05-06 1999-07-07 Electrosols Ltd A method and apparatus for manufacturing consumable tablets
US6284270B1 (en) 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
FR2798289B1 (fr) 1999-09-15 2004-12-31 Cll Pharma Formes galeniques a delitement rapide en bouche et leur procede de preparation
US6375982B1 (en) 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same
DE60134659D1 (de) 2000-11-14 2008-08-14 Orion Corp Vorbeugung der entwicklung von dyskinesie
US6982286B2 (en) * 2001-07-12 2006-01-03 Biotie Therapies Corp. Carbocyclic hydrazino inhibitors of copper-containing amine oxidases
EP1463490B1 (en) 2001-10-12 2011-12-14 MonoSolRX, LLC Glucan based film delivery systems

Also Published As

Publication number Publication date
NO20052752L (no) 2005-06-07
KR20050072820A (ko) 2005-07-12
AU2003276317B2 (en) 2008-08-28
CA2505139A1 (en) 2004-05-21
JP2006506411A (ja) 2006-02-23
DE60311134T2 (de) 2007-10-31
RU2336875C2 (ru) 2008-10-27
NO333977B1 (no) 2013-11-04
NZ539690A (en) 2006-11-30
PL376772A1 (pl) 2006-01-09
IL167889A (en) 2009-07-20
DE60311134D1 (de) 2007-02-22
RU2005117615A (ru) 2006-01-20
CN1711083B (zh) 2010-05-12
CN1711083A (zh) 2005-12-21
AU2003276317A1 (en) 2004-06-07
US20060052429A1 (en) 2006-03-09
WO2004041271A1 (en) 2004-05-21
PT1560581E (pt) 2007-03-30
ES2280846T3 (es) 2007-09-16
EP1560581A1 (en) 2005-08-10
PL211756B1 (pl) 2012-06-29
CA2505139C (en) 2012-02-28
US8653122B2 (en) 2014-02-18
MXPA05004842A (es) 2005-07-22
JP4739758B2 (ja) 2011-08-03
NO20052752D0 (no) 2005-06-07
BR0316071A (pt) 2005-09-27
FI20022007A0 (fi) 2002-11-08
EP1560581B1 (en) 2007-01-10

Similar Documents

Publication Publication Date Title
IS2878B (is) Arípíprazól-samsett lyfjaform og aðferð
DK1539224T3 (da) Antimikrobielt præparat og fremgangsmåde til anvendelse
NO20044148L (no) Sammensetning og fremgangsmate for bronnrensing
DK3417875T3 (da) Immunglobulinformulering og fremgangsmåde til fremstilling deraf
HUE038498T2 (hu) Immunglobulin készítmény és elõállítási módszere
DK1715893T3 (da) Direkte kompressionsformulering og fremgangsmåde
DK1419776T3 (da) Aripiprazol-lægemiddelsubstans med lav hygroskopi og fremgangsmåde til fremstilling af denne
NO20053874D0 (no) Formulering og metoder for behandling av thrombocytemi
IS7966A (is) Pyrazól og aðferðir við að búa þau til og notkun þeirra
DK1490463T3 (da) Lav-transfedtsyrer til konfekture og fedtsammensætninger til bagning
BR0308115B1 (pt) artigo de calÇado e mÉtodo de fabricaÇço de artigo de calÇado
DK1357025T3 (da) Skæreindretning og fremgangmåde til skæring
DK1949936T3 (da) Sammensætning til kontrolleret frigivelse og fremgangsmåde til fremstilling deraf
NO20033854D0 (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
NO20054707L (no) Flytende veksthormonformulering og fremgangsmate til fremstilling derav
DK1589938T3 (da) Mundplejesammensætninger og fremgangsmåder hertil
DK1520587T3 (da) Allergivaccinesammensætning, fremgangsmåde til fremstilling deraf og anvendelse deraf til allergibehandling
NO20030843L (no) Anordning og fremgangsmåte for kultivering
IS7424A (is) Oxasólídínónafleiður, aðferðir til að framleiða þær og lyfjablöndur sem innihalda þær
NO20044342L (no) Androgent farmasoytisk preparat og fremgangsmate for behandling av depresjon
DK1560581T3 (da) Oromucosal formulering og fremgangsmåde for fremstilling deraf
DK1406895T3 (da) Lactonformuleringer og fremgangsmåde til anvendelse deraf
AU2003230320A1 (en) Sustained release formulation of protein and preparation method thereof
EP1710584A4 (en) METHOD OF MEASURING LIPOARABINOMANANE AND ITS USE
DK1482967T3 (da) Farmaceutiske og kosmetiske sammensætninger omfattende plgf-1